Middle Molecule Find

Rulebook › V-tags › V338

V338 Germicide: high-level disinfection inside

Written V0338 on the CMS-2567 and in QCOR.

Enforces ANSI/AAMI RD47:2002/A1:2003, adopted by reference at 42 CFR 494.50(b)(1) · Appendix H Rev. 246, page 159 · checked 12 Nov 2026

Cited on this tag? What happens after a citation · One-page sheet for the binder

The regulation

ANSI/AAMI RD47:2002/A1:2003 Requirements as Adopted by Reference 42 CFR § 494.50(b)(1)

11.4 Germicide

The rinsed and cleaned dialyzer shall be treated by a process that prevents adverse effects caused by microbial contamination. The blood and dialysate compartments of the dialyzer shall be sterilized or subjected to high-level disinfection because an inadequate germicidal process may result in infection in the patient. Low-level disinfection is sufficient for the exterior of the device.

The user shall consult the dialyzer labeling for contraindications or warnings regarding methods and applicability of specific germicidal processes or chemicals.

Read 42 CFR 494.50 on the eCFR

CMS's interpretive guidance

Interpretive Guidance § 494.50(b)(1)

AAMI Rationale for the Development and Provisions of this Recommended Practice

A.11.4 Germicide

In the early 1990s, the FDA began actively regulating all liquid chemical germicides with health care indications. To avoid the potential problem of regulating the same product under multiple classes, the FDA decided to regulate liquid chemical germicides as a separate type of medical device; therefore, it determined that they were unclassified devices. In an effort to ease the burden of this dual regulation, a memorandum of understanding (MOU) was signed between the FDA and the EPA that gave the FDA primary responsibility for premarket efficacy data review of liquid chemical sterilant and high-level disinfectants and gave the EPA primary responsibility for premarket efficacy data review of general purpose disinfectants.

Additionally, the FDA adapted the basic terminology and classification scheme described by Spaulding (1971) to categorize medical devices, and the four levels of processing as proposed by the CDC: sterilization, high-level disinfection, intermediate-level disinfection, and low-level disinfection. Also, the FDA regulatory authority over a particular instrument or medical device dictates that the manufacturer is obligated to provide the user with adequate instructions for the “safe and effective” use of that instrument or device. Those instructions must include methods to clean and disinfect or sterilize the item if it is marketed as a reusable medical device.

Additional Guidance:

The germicide in use must be approved for the dialyzers used at the facility, and the concentration of germicide in the reprocessed dialyzers must be sufficient to achieve the different levels of disinfection needed for the respective parts, i.e. high-level disinfection for treating the blood and dialysate compartments of the dialyzer and low-level disinfection for treating the exterior of the device.

Verbatim from Appendix H Rev. 246, with CMS's headings, lists and bold. Check page 159 (the full 469-page PDF) before quoting it.